Device Trial Radar · NCT03522675
NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test
Last checked: Nov 20, 2026Latest source record: May 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
22
Actual
Start
Apr 11, 2018
Primary completion
Apr 26, 2018
Study completion Apr 28, 2018
Sponsor
- Lead sponsor
- NeXtGen Biologics, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- State University of New York at Buffalo
- First posted
- May 11, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to investigate the potential of NeoMatriXTM Wound Matrix to cause an allergic response to healthy volunteers using a skin prick test.
Conditions
- Allergy Skin
- Allergy
- Dermatitis, Allergic Contact
Interventions
NeoMatriX Wound MatriX Collagen DressingDevice
Collagen wound dressing
Primary outcomes
What the sponsor says the trial is designed to measure.
- Wheal FormationTime frame: 15 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University at Buffalo Clinical and Translational Research Center
Buffalo, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.